Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

NCT03487406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Ticagrelor
DRUG: Aspirin
DRUG: Placebo Aspirin
DRUG: Placebo Ticagrelor

Sponsor

Newcastle-upon-Tyne Hospitals NHS Trust

Collaborators

[object Object]
[object Object]